Preventing Hospitalizations From Acute Exacerbations of Chronic Obstructive Pulmonary Disease

被引:14
作者
Burchette, Jessica E. [1 ]
Campbell, G. Douglas [3 ,4 ]
Geraci, Stephen A. [2 ]
机构
[1] East Tennessee State Univ, Dept Pharm Practice, Gatton Coll Pharm, Maple Ave,Bldg 7,PO 70657, Johnson City, TN 37614 USA
[2] East Tennessee State Univ, Quillen Coll Med, Johnson City, TN USA
[3] Univ Mississippi, Sch Med, Div Pulm Crit Care & Seep Med, Jackson, MS 39216 USA
[4] GV Sonny Montgomery Vet Affairs Med Ctr, Jackson, MS USA
关键词
Chronic lung disease; Hospital admission; Exacerbation; Acute; Treatment; SMOKING-CESSATION INTERVENTION; HEALTH-CARE UTILIZATION; DOUBLE-BLIND; N-ACETYLCYSTEINE; INHALED CORTICOSTEROIDS; FLUTICASONE PROPIONATE; COPD EXACERBATIONS; NONINVASIVE VENTILATION; NEBULIZED BUDESONIDE; ORAL CORTICOSTEROIDS;
D O I
10.1016/j.amjms.2016.06.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic obstructive lung disease is among the leading causes of adult hospital admissions and readmissions in the United States. Preventing acute exacerbations is the primary approach in therapy. Combinations of smoking cessation, pulmonary rehabilitation, vaccinations and inhaled and oral medications may all reduce the overall risk of acute exacerbations. When prevention is unsuccessful, treatment of exacerbations often does not require hospitalization but can be safely executed in the outpatient setting. In the patient who does not require mechanical ventilation or who manifests respiratory acidosis, oxygen supplementation, frequent short-acting inhaled bronchodilators, oral corticosteroids and often antibiotics can abort the decompensation and sometimes return the patient to his or her pre-attack baseline lung function. Several models exist for delivering this care in the ambulatory setting. Follow-up care after an exacerbation has resolved is important, though there are few hard data suggesting which approach is best in this setting.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 163 条
[1]   Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease [J].
Aaron, SD ;
Vandemheen, KL ;
Hebert, P ;
Dales, R ;
Stiell, IG ;
Ahuja, J ;
Dickinson, G ;
Brison, R ;
Rowe, BH ;
Dreyer, J ;
Yetisir, E ;
Cass, D ;
Wells, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) :2618-2625
[2]   Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease - A randomized trial [J].
Aaron, Shawn D. ;
Vandemheen, Katherine L. ;
Fergusson, Dean ;
Maltais, Francois ;
Bourbeau, Jean ;
Goldstein, Roger ;
Balter, Meyer ;
O'Donnell, Denis ;
McIvor, Andrew ;
Sharma, Sat ;
Bishop, Graham ;
Anthony, John ;
Cowie, Robert ;
Field, Stephen ;
Hirsch, Andrew ;
Hernandez, Paul ;
Rivington, Robert ;
Road, Jeremy ;
Hoffstein, Victor ;
Hodder, Richard ;
Marciniuk, Darcy ;
McCormack, David ;
Fox, George ;
Cox, Gerard ;
Prins, Henry B. ;
Ford, Gordon ;
Bleskie, Dominique ;
Doucette, Steve ;
Mayers, Irvin ;
Chapman, Kenneth ;
Zamel, Noe ;
FitzGerald, Mark .
ANNALS OF INTERNAL MEDICINE, 2007, 146 (08) :545-U15
[3]   Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD [J].
Adams, SG ;
Melo, J ;
Luther, M ;
Anzueto, A .
CHEST, 2000, 117 (05) :1345-1352
[4]   Interactions of glucocorticoids and beta(2)-agonists [J].
Adcock, IM ;
Stevens, DA ;
Barnes, PJ .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (01) :160-168
[5]   Efficacy of two corticosteroid regimens in acute exacerbation of chronic obstructive pulmonary disease [J].
Aggarwal, P. ;
Wig, N. ;
Bhoi, S. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (05) :687-692
[6]   Azithromycin for Prevention of Exacerbations of COPD [J].
Albert, Richard K. ;
Connett, John ;
Bailey, William C. ;
Casaburi, Richard ;
Cooper, J. Allen D., Jr. ;
Criner, Gerard J. ;
Curtis, Jeffrey L. ;
Dransfield, Mark T. ;
Han, MeiLan K. ;
Lazarus, Stephen C. ;
Make, Barry ;
Marchetti, Nathaniel ;
Martinez, Fernando J. ;
Madinger, Nancy E. ;
McEvoy, Charlene ;
Niewoehner, Dennis E. ;
Porsasz, Janos ;
Price, Connie S. ;
Reilly, John ;
Scanlon, Paul D. ;
Sciurba, Frank C. ;
Scharf, Steven M. ;
Washko, George R. ;
Woodruff, Prescott G. ;
Anthonisen, Nicholas R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08) :689-698
[7]   Clinical efficacy of anti-pneumococcal vaccination in patients with COPD [J].
Alfageme, I ;
Vazquez, R ;
Reyes, N ;
Muñoz, J ;
Fernández, A ;
Hernandez, M ;
Merino, M ;
Perez, J ;
Lima, J .
THORAX, 2006, 61 (03) :189-195
[8]   HEALTH-EFFECTS OF AN AIR-POLLUTION EPISODE IN LONDON, DECEMBER 1991 [J].
ANDERSON, HR ;
LIMB, ES ;
BLAND, JM ;
DELEON, AP ;
STRACHAN, DP ;
BOWER, JS .
THORAX, 1995, 50 (11) :1188-1193
[9]   Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: Results from the APHEA project [J].
Anderson, HR ;
Spix, C ;
Medina, S ;
Schouten, JP ;
Castellsague, J ;
Rossi, G ;
Zmirou, D ;
Touloumi, G ;
Wojtyniak, B ;
Ponka, A ;
Bacharova, L ;
Schwartz, J ;
Katsouyanni, K .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (05) :1064-1071
[10]  
[Anonymous], 1980, Ann Intern Med, V93, P391